Skip to main content
Jivesh Sharma, MD, Oncology, Dallas, TX

JiveshJSharmaMD

Oncology Dallas, TX

Hematologic Oncology

Physician

Dr. Sharma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sharma's full profile

Already have an account?

  • Office

    7777 Forest Ln
    Ste B242
    Dallas, TX 75230
    Phone+1 214-739-1706
    Fax+1 214-368-1611

Summary

  • Boarded in Medical Oncology

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1991 - 1993
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1987 - 1990
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 1987
  • The University of Texas at Arlington
    The University of Texas at ArlingtonBS, Biology, 1983

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2019 - 2025
  • TX State Medical License
    TX State Medical License 1989 - 2024
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Best Doctors in Dallas D Magazine, 2001-2002, 2004-2006
  • Member at large Medical Board Presbyterian Hospital, 1999
  • Jacob S. Krakusin Teaching Award Internal Medicine Housestaff, 1994
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Transformation of the Healthcare System Through Internet Technologies  
    Sharma J, Dallas County Medical Society Journal, 1/1/1998
  • Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer  
    Sharma JJ, Razvillas B, Stephens CD, Hilsenbeck SG, Sharma A, Rothenberg ML, Investigational New Drugs, 1/1/1997
  • Prognostic significance of insulin-like growth factor- binding protein expression in axillary lymph node-negative breast cancer  
    Douglas Yee, Jivesh Sharma, Susan G. Hilsenbeck, Journal of the National Cancer Institute, 1/1/1994
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Extending Oncology Clinical Services To Rural Areas of Texas Via Teleoncology.
    J. Sharma, Gary Gross, Poonam Sharma, Journal of Oncology Practice, 1/1/2012
  • Results of treatment of stage III-B osteogenic sarcoma utilizing preoperative ifosfamide followed by a wide resection of the tumor and wedge resection of the pulmonary...
    G.E. Maale, J. Sharma, M.F. Richie, Proceedings of the American Society of Clinical Oncology, Dallas/Fortworth Sarcoma Group, Dallas, TX, 1/1/1994
  • Multimodality treatment for stage IIB soft tissue sarcoma .
    G. Maale, J. Strauss, M. Richie, D. Schawrz, K. McIntyre, S. Helms, M. Sunderland, J. Sharma, P. Jensen, M. Pollock, B. Dickson, and H. Pascoe, Proceedings of the American Society of Clinical Oncology, Presbyterian Hospital Comprehensive Cancer Center, Dallas, TX, 1/1/1994
  • Join now to see all

Lectures

  • The Power of Convergence 
    1/1/2011
  • Oncology Outlook - Next Generation Care 
    1/1/2008
  • Algorithms in Clinical Care 
    1/1/2008
  • Join now to see all

Other

  • HPV Vaccination for Cervical Cancer 
    Sharma J, KETK East Texas Live Evening News
    1/1/2011
  • Keynote speaker College of Science Graduation 
    Sharma J
    UT Arlington - 1/1/2011
  • Morning Show discussion of next generation cancer care 
    Sharma J, KTEK East Texas Live
    1/1/2010
  • Join now to see all

Press Mentions

  • Verdi Oncology Launches Verdi Cancer and Research Center of Texas
    Verdi Oncology Launches Verdi Cancer and Research Center of TexasAugust 6th, 2019
  • Pharos Capital Group-Backed Verdi Oncology Expands into Dallas with Community Care and Research Options
    Pharos Capital Group-Backed Verdi Oncology Expands into Dallas with Community Care and Research OptionsAugust 6th, 2019
  • An Oncologist on Pesticides and Cancer
    An Oncologist on Pesticides and CancerAugust 11th, 2022